Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Biomaterial-Based Sustained-Release Drug Formulations for Localized Cancer Immunotherapy

Published:2023-12-05 Issue: Volume: Page:
ISSN:2576-6422
Container-title:ACS Applied Bio Materials
language:en
Short-container-title:ACS Appl. Bio Mater.

Author:

Mujahid Khizra¹,Rana Isra¹,Suliman Ivan Hardianto¹,Li Zhen¹,Wu Jiang²^ORCID,He Huacheng³^ORCID,Nam Jutaek¹^ORCID

Affiliation:

1. College of Pharmacy, Chonnam National University, Gwangju 61186, South Korea

2. School of Pharmaceutical Sciences, Key Laboratory of Biotechnology and Pharmaceutical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

3. Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Wenzhou, Zhejiang 325000, P. R. China

Funder

Chonnam National University

National Research Foundation of Korea

Publisher

American Chemical Society (ACS)

Subject

Biochemistry (medical),Biomedical Engineering,General Chemistry,Biomaterials

Link

https://pubs.acs.org/doi/pdf/10.1021/acsabm.3c00808

Reference195 articles.

1. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization

2. Harnessing the immune system to improve cancer therapy

3. Adaptive immunity maintains occult cancer in an equilibrium state

4. Cancer nanomedicine for combination cancer immunotherapy

5. Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP